Clusterin Regulates Drug-Resistance in Melanoma Cells
- 1 June 2005
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 124 (6) , 1300-1307
- https://doi.org/10.1111/j.0022-202x.2005.23720.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Apoptosis and melanoma chemoresistanceOncogene, 2003
- Synthesis and Functional Analyses of Nuclear Clusterin, a Cell Death ProteinJournal of Biological Chemistry, 2003
- Antisense therapy for cancer—the time of truthThe Lancet Oncology, 2002
- Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progressionOncogene, 2002
- ClusterinThe International Journal of Biochemistry & Cell Biology, 2002
- Acquisition of Resistance to Fas-Mediated Apoptosis by Overexpression of Clusterin in Human Renal-Cell Carcinoma CellsMolecular Urology, 2001
- Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditisJournal of Clinical Investigation, 2000
- Overexpression of Clusterin in Human Breast CarcinomaThe American Journal of Pathology, 2000
- Clusterin Gene Expression Mediates Resistance to Apoptotic Cell Death Induced by Heat Shock and Oxidative StressJournal of Investigative Dermatology, 1999
- Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomasZeitschrift für Krebsforschung und Klinische Onkologie, 1994